Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis. [electronic resource]
Producer: 20190403Description: 946-957.e18 p. digitalISSN:- 1528-0012
- Adult
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- C-Reactive Protein -- metabolism
- CD4-Positive T-Lymphocytes -- metabolism
- Colitis, Ulcerative -- drug therapy
- Feces -- chemistry
- Female
- Gastrointestinal Agents -- administration & dosage
- Humans
- Integrins -- antagonists & inhibitors
- Intestinal Mucosa
- Leukocyte L1 Antigen Complex -- analysis
- Male
- Middle Aged
- Remission Induction
- Severity of Illness Index
- Treatment Outcome
- Wound Healing -- drug effects
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.